Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

Investing.com -- Longeveron Inc. (NASDAQ: LGVN) stock surged 23% after the U.S. Food and Drug Administration approved the company’s Investigational New Drug (IND) application for laromestrocel, a ...

The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.